Huang P

ORCID: 0009-0004-3736-100X · 30 papers in corpus
other 2019
Journal of translational medicine ·doi:10.1186/s12967-019-1897-0

BACKGROUND: The role of γδ T cells, innate-like lymphocytes with unrestrained MHC, in various malignancies has recently been extensively studied. However, there is limited research regarding γδ T cells in ovarian cancer (OC) patients. METH…

meta-analysis 2019
Disease markers ·doi:10.1155/2019/7541857

Current screening tests for the diagnosis of ovarian cancer (OC) face enduring challenges. However, microRNAs (miRNAs) are stable in the circulation and may be promising molecular biomarkers for OC prediction. Circulating miRNA expression p…

other 2018
Frontiers in pharmacology ·doi:10.3389/fphar.2018.01095

Background: Valproic acid (VPA) and topiramate (TPM), initially developed as antiepileptics, are approved for migraine prophylaxis in adults but not children. The differences in their antimigraine mechanism(s) by age remain unclear. Methods…

nonrandomized-trial 2017
Medicine ·doi:10.1097/md.0000000000006752

BACKGROUND: The red cell distribution width (RDW) has attracted attention in the diagnosis of malignant tumors. In this study, we analyzed the correlation between the RDW and ovarian cancer by observing changes in the RDW in patients with o…

other 2015
Cancer Immunology, Immunotherapy ·doi:10.1007/s00262-014-1632-x

Inflammation has been implicated in the initiation and progression of ovarian cancer (OC), the underlying mechanisms of which are still unclear. We hypothesized that the abnormal expression of Toll-like receptors (TLRs), which were potentia…